179 related articles for article (PubMed ID: 34249078)
1. Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma.
Song W; He X; Gong P; Yang Y; Huang S; Zeng Y; Wei L; Zhang J
Front Genet; 2021; 12():639246. PubMed ID: 34249078
[No Abstract] [Full Text] [Related]
2. Mitochondrial energy metabolism-related gene signature as a prognostic indicator for pancreatic adenocarcinoma.
Ma Y; Tang R; Huang P; Li D; Liao M; Gao S
Front Pharmacol; 2024; 15():1332042. PubMed ID: 38572434
[No Abstract] [Full Text] [Related]
3. Construction and validation of a novel immunological model to predict prognosis in pancreatic ductal adenocarcinoma.
Liu J; He M
Int Immunopharmacol; 2024 May; 134():112266. PubMed ID: 38761784
[TBL] [Abstract][Full Text] [Related]
4. Integrating Tertiary Lymphoid Structure-Associated Genes into Computational Models to Evaluate Prognostication and Immune Infiltration in Pancreatic Cancer.
Ma Y; Li X; Zhang J; Zhao X; Lu Y; Shen G; Wang G; Liu H; Hao J
J Leukoc Biol; 2024 Mar; ():. PubMed ID: 38484172
[TBL] [Abstract][Full Text] [Related]
5. Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity.
Wang M; Liu L; Li X; Jiang W; Xiao J; Hao Q; Wang J; Reddy AV; Talbot A; Ikuta S; Tian D; Ren L
J Gastrointest Oncol; 2024 Apr; 15(2):730-746. PubMed ID: 38756638
[TBL] [Abstract][Full Text] [Related]
6. Unraveling Pancreatic Ductal Adenocarcinoma Immune Prognostic Signature through a Naive B Cell Gene Set.
Zhang S; Ta N; Zhang S; Li S; Zhu X; Kong L; Gong X; Guo M; Liu Y
Cancer Lett; 2024 May; ():216981. PubMed ID: 38795761
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma.
Lin J; Liu P; Sun K; Jiang L; Liu Y; Huang Y; Liu J; Shi M; Zhang J; Wang T; Shen B
Cancer Cell Int; 2024 May; 24(1):177. PubMed ID: 38773440
[TBL] [Abstract][Full Text] [Related]
8. Development of a basement membrane gene signature and identification of the potential candidate therapeutic targets for pancreatic cancer.
Lin K; Xu D; Wang X; Shi J; Gao W
Gland Surg; 2023 Feb; 12(2):263-281. PubMed ID: 36915817
[TBL] [Abstract][Full Text] [Related]
9. The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data.
Wang W; Chen G; Zhang W; Zhang X; Huang M; Li C; Wang L; Lu Z; Xia J
Hum Genet; 2024 Mar; ():. PubMed ID: 38526745
[TBL] [Abstract][Full Text] [Related]
10. A Novel HOXA10-Associated 5-Gene-Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma.
Kisling SG; Atri P; Shah A; Cox JL; Sharma S; Smith LM; Ghersi D; Batra SK
Clin Cancer Res; 2023 Sep; 29(18):3759-3770. PubMed ID: 37432996
[TBL] [Abstract][Full Text] [Related]
11. Deciphering fatty acid biosynthesis-driven molecular subtypes in pancreatic ductal adenocarcinoma with prognostic insights.
Xu J; Liu M; Xue J; Lu P
Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38753153
[TBL] [Abstract][Full Text] [Related]
12. A prognostic score based on long-term survivor unique transcriptomic signatures predicts patient survival in pancreatic ductal adenocarcinoma.
Katsuta E; Huyser M; Yan L; Takabe K
Am J Cancer Res; 2021; 11(9):4294-4307. PubMed ID: 34659888
[TBL] [Abstract][Full Text] [Related]
13. An ion channel-based prognostic model identified TRPV2 and GJB3 as immunotherapy determinants in pancreatic cancer.
Mao J; Tian Y; Luo N
Heliyon; 2024 Apr; 10(7):e27301. PubMed ID: 38560261
[TBL] [Abstract][Full Text] [Related]
14. A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.
Haider S; Wang J; Nagano A; Desai A; Arumugam P; Dumartin L; Fitzgibbon J; Hagemann T; Marshall JF; Kocher HM; Crnogorac-Jurcevic T; Scarpa A; Lemoine NR; Chelala C
Genome Med; 2014; 6(12):105. PubMed ID: 25587357
[TBL] [Abstract][Full Text] [Related]
15. Potential role of lipophagy impairment for anticancer effects of glycolysis-suppressed pancreatic ductal adenocarcinoma cells.
Zhang Z; Aoki H; Umezawa K; Kranrod J; Miyazaki N; Oshima T; Hirao T; Miura Y; Seubert J; Ito K; Aoki S
Cell Death Discov; 2024 Apr; 10(1):166. PubMed ID: 38580661
[TBL] [Abstract][Full Text] [Related]
16. Expression of Genomic Instability-Related Molecules: Cyclin F, RRM2 and SPDL1 and Their Prognostic Significance in Pancreatic Adenocarcinoma.
Klimaszewska-Wiśniewska A; Buchholz K; Neska-Długosz I; Durślewicz J; Grzanka D; Zabrzyński J; Sopońska P; Grzanka A; Gagat M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670609
[TBL] [Abstract][Full Text] [Related]
17. Intron retention is a robust marker of intertumoral heterogeneity in pancreatic ductal adenocarcinoma.
Tan DJ; Mitra M; Chiu AM; Coller HA
NPJ Genom Med; 2020 Dec; 5(1):55. PubMed ID: 33311498
[TBL] [Abstract][Full Text] [Related]
18. Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer.
Fu Y; Tao J; Gu Y; Liu Y; Qiu J; Su D; Wang R; Luo W; Liu T; Zhang F; Zhang T; Zhao Y
NPJ Precis Oncol; 2024 May; 8(1):109. PubMed ID: 38769374
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
Front Immunol; 2021; 12():690056. PubMed ID: 34335594
[TBL] [Abstract][Full Text] [Related]
20. GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer.
Yang Y; He X; Tang QQ; Shao YC; Song WJ; Gong PJ; Zeng YF; Huang SR; Zhou JY; Wan HF; Wei L; Zhang JW
Front Oncol; 2021; 11():629633. PubMed ID: 34367945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
